3Fritsch NM,Schiffrin EL.A1dosterone:a risk factor for vascular disease.Curr Hypertens Rep,2003,5(1):59.
4Bravo EL.Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease.Curr Hypertens Rep,2003,5(2):122.
5Pitt B,Zanond F,Remmc WJ et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure.N Engl J Med,1999,341:709.
7Krum H,Nolly H,Workman D et al.Efficacy of eplerenone added to rennin-angiotensin blockade in hypertensive patients.Hypertension,2002,40(2):117.
8Flack JM,Oparil S,Pratt JH et al.Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.J Am Coll Cardiol,2003,41(7):1156.
9White WB,Duprez D,Sthillaire R et al.Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.Hypertension,2003,41(5):1021.
10Pitt B,Remme W,Zannad F et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction.N Engl J Med,2003,348:1309.
